Lithium Hydroxide → 2-(5-{3-[5-(4,5,6,7-Tetrahydro-benzothiazol-2-yl)-pyridin-2-yloxy]-propoxy}-indol-1-yl)-propionic acid

HRID 734438ノート

反応式

HRID 734438 の反応式
[S:1]1[C:5]2[CH2:6][CH2:7][CH2:8][CH2:9][C:4]=2[N:3]=[C:2]1[C:10]1[CH:11]=[CH:12][C:13]([O:16][CH2:17][CH2:18][CH2:19][OH:20])=[N:14][CH:15]=1.C[O:22][C:23](=[O:36])[CH:24]([N:26]1[C:34]2[C:29](=[CH:30][C:31](O)=[CH:32][CH:33]=2)[CH:28]=[CH:27]1)[CH3:25].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.N(C(N1CCCCC1)=O)=NC(N1CCCCC1)=O.[Li+].[OH-]>C(Cl)Cl>[S:1]1[C:5]2[CH2:6][CH2:7][CH2:8][CH2:9][C:4]=2[N:3]=[C:2]1[C:10]1[CH:11]=[CH:12][C:13]([O:16][CH2:17][CH2:18][CH2:19][O:20][C:31]2[CH:30]=[C:29]3[C:34](=[CH:33][CH:32]=2)[N:26]([CH:24]([CH3:25])[C:23]([OH:36])=[O:22])[CH:27]=[CH:28]3)=[N:14][CH:15]=1

参加物

7

反応物 5

HCID 3939Lithium HydroxideHCID 11776TriphenylphosphineHCID 730421,1'-(Azodicarbonyl)dipiperidineHCID 578453663-[5-(4,5,6,7-Tetrahydro-benzothiazol-2-yl)-pyridin-2-yloxy]-propan-1-olHCID 57845447methyl 2-(5-hydroxy-1H-indol-1-yl)propanoate

生成物 1

HCID 578453642-(5-{3-[5-(4,5,6,7-Tetrahydro-benzothiazol-2-yl)-pyridin-2-yloxy]-propoxy}-indol-1-yl)-propionic acid収率 4.7%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

To a solution of 3-[5-(4,5,6,7-tetrahydro-benzothiazol-2-yl)-pyridin-2-yloxy]-propan-1-ol (Example 78, 0.098 g, 0.34 mmol) and 2-(5-hydroxy-indol-1-yl)-propionic acid methyl ester (Example 7, 0.067 g, 0.31 mmol) in CH2Cl2 (10 mL) were added triphenylphosphine (0.161 g, 0.61 mmol) and 1,1′-(azodicarbonyl)-dipiperidine (0.155 g, 0.61 mmol). The yellow reaction mixture was stirred at rt for 18 h, then diluted with 20 mL hexanes, and filtered through a short pad of silica gel. The filtrate was concentrated under reduced pressure, and the residue (0.065 g) dissolved in 5 mL of a mixture of methanol/THF/water (2:2:1). LiOH (9.1 mg, 0.37 mmol) was added. The mixture was stirred at rt for 18 h and concentrated under reduced pressure. The residue was taken up in water and washed with ether. The aqueous layer was acidified to pH 3.5 and extracted with ethyl acetate. The combined organic layers were dried over Na2SO4, filtered, and concentrated to give the title compound (7 mg, 4%). 1H NMR (400 MHz, acetone-d6) δ 8.20 (dd, 1H), 7.90 (dd, 1H), 7.35 (s, 1H), 7.29 (dd, 1H), 7.11 (s, 1H), 6.85 (dd, 1H), 6.50 (dd, 1H), 6.39 (s, 1H), 5.25-5.35 (m, 1H), 4.31 (t, 2H), 4.31 (t, 2H), 4.08 (t, 2H), 2.95-3.05 (br s, 1H), 2.70-2.78 (m, 4H), 2.30-2.35 (m, 2H), 1.70-1.94 (m, 4H). LC/MS m/z 478.2 (M+H)+, RT 2.90 min.

後処理

  1. filtrationfiltered through a short pad of silica gel
  2. concentrationThe filtrate was concentrated under reduced pressure
  3. dissolutionthe residue (0.065 g) dissolved in 5 mL of a mixture of methanol/THF/water (2:2:1)
  4. stirringThe mixture was stirred at rt for 18 h
  5. concentrationconcentrated under reduced pressure
  6. washwashed with ether
  7. extractionextracted with ethyl acetate
  8. dry with materialThe combined organic layers were dried over Na2SO4
  9. filtrationfiltered
  10. concentrationconcentrated

出典と根拠

ORDレコード
ord-da703bee53124743bb174024b522ccf8
出典データセット
uspto-grants-2009_09
特許番号
US07592361B2

反応ノート

読み込み中…